ARTA
ESPR icon

A.R.T. Advisors’s Esperion Therapeutics ESPR Stock Holding History

A.R.T. Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,600
Closed -$902K – 1440
2019
Q3 		$902K Buy
24,600
+16,400
+200% +$650K 0.05% 597
2019
Q2 		$381K Sell
8,200
-59,443
-88% -$2.79M 0.02% 856
2019
Q1 		$2.72M Buy
67,643
+17,200
+34% +$772K 0.16% 159
2018
Q4 		$2.32M Buy
50,443
+41,400
+458% +$1.99M 0.15% 196
2018
Q3 		$401K Buy
+9,043
New +$415K 0.02% 938
2018
Q2 		– Sell
-50,143
Closed -$3.63M – 1519
2018
Q1 		$3.63M Buy
+50,143
New +$3.68M 0.15% 179
2017
Q4 		– Sell
-30,560
Closed -$1.53M – 1448
2017
Q3 		$1.53M Sell
30,560
-24,900
-45% -$1.2M 0.08% 364
2017
Q2 		$2.57M Buy
+55,460
New +$2.04M 0.14% 203
2016
Q3 		– Sell
-23,650
Closed -$233K – 792
2016
Q2 		$233K Sell
23,650
-177,208
-88% -$2.94M 0.01% 1051
2016
Q1 		$3.4M Buy
200,858
+97,112
+94% +$1.56M 0.15% 189
2015
Q4 		$2.31M Buy
103,746
+69,713
+205% +$1.76M 0.11% 247
2015
Q3 		$802K Buy
+34,033
New +$2.14M 0.03% 705
2015
Q2 		– Sell
-43,696
Closed -$4.05M – 1539
2015
Q1 		$4.05M Buy
43,696
+9,255
+27% +$597K 0.14% 194
2014
Q4 		$1.39M Buy
+34,441
New +$1.05M 0.05% 513

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

A.R.T. Advisors's ESPR Position: Q4 2019 in Review

A.R.T. Advisors sold out of Esperion Therapeutics (ESPR) in Q4 2019, closing a stake of 24,600 shares — an estimated $902K sold.

A.R.T. Advisors first reported a position in ESPR in Q4 2014 and held it in 14 quarters. The position peaked at $4.05M in Q1 2015. 172 funds tracked by Wall St. Rank hold ESPR as of Q4 2019.

  • A.R.T. Advisors reported no remaining Esperion Therapeutics position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 24,600 Esperion Therapeutics shares in Q4 2019, an estimated $902K.
  • A.R.T. Advisors first reported a position in Esperion Therapeutics in Q4 2014 and held it in 14 quarters.
  • A.R.T. Advisors's Esperion Therapeutics position peaked at $4.05M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.